# OnCo record radioimmunotherapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/radioimmunotherapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "radioimmunotherapy" ;
  schema:name "Radio-antibody & radio-ADC"@en ;
  schema:description "Attaching a radioactive atom to an antibody, so an ADC's targeting is used to deliver radiation instead of chemotherapy."@en ;
  schema:url <https://onco.cc/technologies/radioimmunotherapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Radioimmunotherapy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q2126427> ;
  schema:citation <https://en.wikipedia.org/wiki/Radioimmunotherapy> ;
  onco:status "phase-2" ;
  onco:tag "frontier" ;
  onco:related <https://onco.cc/ideas/idea-alpha-after-adc/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  onco:targets <https://onco.cc/targets/psma/>, <https://onco.cc/targets/cd33/>, <https://onco.cc/targets/dll3/>, <https://onco.cc/targets/her2/> ;
  onco:companies <https://onco.cc/companies/abdera-therapeutics/>, <https://onco.cc/companies/actinium-pharmaceuticals/>, <https://onco.cc/companies/convergent-therapeutics/> ;
  onco:journals <https://onco.cc/journals/cancer-biotherapy-and-radiopharmaceuticals/> ;
  onco:dependsOn <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/therapy-isotope-supply-chain/> .